Jinglong Chen
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC (NCT04157140) | Jinglong Chen | 2019-11-28 |
Track Jinglong Chen automatically
Every clearance here is in the API, with alerts when new ones post.